Central neurocytoma is a rare WHO Grade 2 tumor that typically occurs in the lateral ventricle. In rare cases, central neurocytomas can also occur in the third ventricle1. The most common initial presentation is caused by increased intracranial pressure or ventriculomegaly.
WHO Classification
According to the WHO classification, central neurocytomas belong to the group of glioneuronal and neuronal tumors and are classified as WHO Grade 2.
Epidemiology
Central neurocytoma accounts for approximately 0.1 - 0.5 % of all brain tumors. Incidence is highest in the third decade of life. However, central neurocytoma can occur at any age, with an equal distribution between women and men.
Localization
Central neurocytoma typically arises from the septum pellucidum, the fornix, or the wall of the lateral ventricle2.
Symptoms
Central neurocytomas usually become symptomatic through symptoms of increased intracranial pressure: headache, vomiting, nausea, visual deficits, or papilledema. Epileptic seizures, memory impairment, or motor deficits may also occur3.
Imaging
CT Imaging
On CT imaging, calcifications are present in 25-50 % of central neurocytomas, which typically appear iso- to hyperdense, with hypodense areas corresponding to cystic changes4. On contrast-enhanced sequences, the tumor demonstrates moderate to intense contrast enhancement5.
MRI Imaging
On MRI, central neurocytomas appear heterogeneously isointense on T1-weighted sequences and hyperintense on T2-weighted sequences. MR spectroscopy frequently demonstrates a high glycine peak6. MRI also shows moderate to intense contrast enhancement of the tumor7.
Treatment
Complete tumor resection is often curative, and additional radiation therapy is usually not necessary after a gross total resection (GTR)8. In cases of subtotal resection, surgical treatment can be combined with stereotactic radiation therapy9 10 11 12. After successful treatment, long-term follow-up with imaging should be performed to rule out recurrence13.
References
Patel DM, Schmidt RF, Liu JK. Update on the diagnosis, pathogenesis, and treatment strategies for central neurocytoma. J Clin Neurosci. 2013;20:1193-1199. ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩
Neurosurgery Case Review: Questions and Answers. Remi Nader, Abdulrahman J Sabbagh. 2020 Thieme Verlage. ISBN 9781626231986 ↩ ↩ ↩ ↩
Sharma MC, Deb P, Sharma S, et al. Neurocytoma: a comprehensive review. Neurosurg Rev. 2006;29:270-85; discussion 285. ↩ ↩ ↩ ↩ ↩ ↩ ↩ ↩
Kaur G, Kane AJ, Sughrue ME, et al. MIB-1 labeling index predicts recurrence in intraventricular central neurocytomas. J Clin Neurosci. 2013;20:89-93. ↩ ↩ ↩ ↩
Handbook of Neurosurgery. Greenberg M, ed. 9th Edition. Thieme; 2019. ↩ ↩